| Multiple sclerosis: geoepidemiology, genetics and the environment R Milo, E Kahana Autoimmunity reviews 9 (5), A387-A394, 2010 | 1024 | 2010 |
| Revised diagnostic criteria of multiple sclerosis R Milo, A Miller Autoimmunity reviews 13 (4-5), 518-524, 2014 | 495 | 2014 |
| Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. NK De Rosbo, R Milo, MB Lees, D Burger, CC Bernard, A Ben-Nun The Journal of clinical investigation 92 (6), 2602-2608, 1993 | 415 | 1993 |
| The increasing incidence and prevalence of female multiple sclerosis—a critical analysis of potential environmental factors J Sellner, J Kraus, A Awad, R Milo, B Hemmer, O Stüve Autoimmunity reviews 10 (8), 495-502, 2011 | 258 | 2011 |
| Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against … NK De Rosbo, M Hoffman, I Mendel, I Yust, J Kaye, R Bakimer, S Flechter, ... European journal of immunology 27 (11), 3059-3069, 1997 | 221 | 1997 |
| Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. D Teitelbaum, R Milo, R Arnon, M Sela Proceedings of the National Academy of Sciences 89 (1), 137-141, 1992 | 167 | 1992 |
| Immunological aspects of approved MS therapeutics PS Rommer, R Milo, MH Han, S Satyanarayan, J Sellner, L Hauer, Z Illes, ... Frontiers in immunology 10, 1564, 2019 | 150 | 2019 |
| Interferon β-lb reduces Interferon γ-induced antigen-presenting capacity of human glial and B cells H Jiang, R Milo, P Swoveland, KP Johnson, H Panitch, S Dhib-Jalbut Journal of neuroimmunology 61 (1), 17-25, 1995 | 144 | 1995 |
| Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases O Elkayam, D Paran, R Milo, Y Davidovitz, D Almoznino-Sarafian, ... Annals of the rheumatic diseases 59 (1), 77-77, 2000 | 136 | 2000 |
| Switching from natalizumab to fingolimod: a randomized, placebo-controlled study in RRMS L Kappos, EW Radue, G Comi, X Montalban, H Butzkueven, H Wiendl, ... Neurology 85 (1), 29-39, 2015 | 135 | 2015 |
| Diagnostic criteria in autoimmune diseases Y Shoenfeld, R Cervera, ME Gershwin Springer Science & Business Media, 2010 | 130 | 2010 |
| Treatment with oral 3, 4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial CT Bever Jr, PA Anderson, J Leslie, HS Panitch, S Dhib-Jalbut, OA Khan, ... Neurology 47 (6), 1457-1462, 1996 | 107 | 1996 |
| Therapeutic strategies targeting B-cells in multiple sclerosis R Milo Autoimmunity reviews 15 (7), 714-718, 2016 | 92 | 2016 |
| Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel C Klein, I Kimiagar, L Pollak, R Gandelman-Marton, A Itzhaki, R Milo, ... Journal of the neurological sciences 200 (1-2), 63-66, 2002 | 92 | 2002 |
| Delayed epidural hematoma a review R Milo, N Razon, J Schiffer Acta neurochirurgica 84, 13-23, 1987 | 88 | 1987 |
| The myelin-associated oligodendrocytic basic protein region MOBP15–36 encompasses the immunodominant major encephalitogenic epitope (s) for SJL/J mice and predicted epitope (s … NK De Rosbo, JF Kaye, M Eisenstein, I Mendel, R Hoeftberger, ... The Journal of Immunology 173 (2), 1426-1435, 2004 | 76 | 2004 |
| Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein R Milo, H Panitch Journal of neuroimmunology 61 (2), 185-193, 1995 | 75 | 1995 |
| Multiple sclerosis frequency in Israel’s diverse populations M Alter, E Kahana, N Zilber, A Miller Neurology 66 (7), 1061-1066, 2006 | 71 | 2006 |
| Therapies for multiple sclerosis targeting B cells R Milo Croatian medical journal 60 (2), 87, 2019 | 64 | 2019 |
| Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines (vol 6, pg S1, 1999) D Paty, H Hartung, G Ebers, P SoelbergSorensen, O Abramsky, ... European Journal of Neurology 6 (6), 1999 | 61 | 1999 |
